Related references
Note: Only part of the references are listed.Analytical Methods for Determination of Apremilast from Bulk, Dosage Form and Biological Fluids: A Critical Review
Pooja Kulkarni et al.
CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY (2021)
COVID-19 vaccination intention among patients with psoriasis compared with immunosuppressed patients with other skin diseases and factors influencing their decision
E. Sotiriou et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
COVID-19 vaccination and patients with psoriasis under biologics: real-life evidence on safety and effectiveness from Italian vaccinated healthcare workers
G. Damiani et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2021)
Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: Real-life data from a large cohort during red-zone declaration
Giovanni Damiani et al.
DERMATOLOGIC THERAPY (2020)
COVID-19 knowledge prevents biologics discontinuation: Data from an Italian multicenter survey during RED-ZONE declaration
Nicola Luigi Bragazzi et al.
DERMATOLOGIC THERAPY (2020)
Severe bitter taste associated with apremilast
Giovanni Damiani et al.
DERMATOLOGIC THERAPY (2019)
Management of Common Side Effects of Apremilast
Annie Langley et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2018)
Share Paper
